MALDI imaging mass spectrometry analysis-A new approach for protein mapping in multiple sclerosis brain lesions.
暂无分享,去创建一个
S. Deininger | C. Turck | J. Hornung | F. Weber | C. Stadelmann | G. Maccarrone | F. König | S. Nischwitz
[1] M. Trojano,et al. Proteomic Profiling in Multiple Sclerosis Clinical Courses Reveals Potential Biomarkers of Neurodegeneration , 2014, PloS one.
[2] R. Franklin,et al. Macrophages and CNS remyelination , 2014, Journal of neurochemistry.
[3] Jonas Bergquist,et al. MALDI imaging of post‐mortem human spinal cord in amyotrophic lateral sclerosis , 2013, Journal of neurochemistry.
[4] M. Chopp,et al. Thymosin beta 4 mediates oligodendrocyte differentiation by upregulating p38 MAPK , 2012, Glia.
[5] M. Chopp,et al. Treatment of neurological injury with thymosin β4 , 2012, Annals of the New York Academy of Sciences.
[6] M. Chopp,et al. Neuroprotective and neurorestorative effects of thymosin β4 treatment initiated 6 hours after traumatic brain injury in rats. , 2012, Journal of neurosurgery.
[7] H. Hartung,et al. Enhancing remyelination in disease--can we wrap it up? , 2011, Brain : a journal of neurology.
[8] C. Wegner,et al. Inflammation, demyelination, and degeneration - recent insights from MS pathology. , 2011, Biochimica et biophysica acta.
[9] M. Chopp,et al. Thymosin β4 improves functional neurological outcome in a rat model of embolic stroke , 2010, Neuroscience.
[10] Detlev Suckau,et al. Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry. , 2010, Journal of proteome research.
[11] M. Chopp,et al. Neurological functional recovery after thymosin beta4 treatment in mice with experimental auto encephalomyelitis , 2009, Neuroscience.
[12] F. Holsboer,et al. Regulation of proteins mediating neurodegeneration in experimental autoimmune encephalomyelitis and multiple sclerosis , 2009, Proteomics. Clinical applications.
[13] Maxence Wisztorski,et al. MALDI Imaging Mass Spectrometry , 2009, Molecular & Cellular Proteomics.
[14] Sören-Oliver Deininger,et al. MALDI imaging combined with hierarchical clustering as a new tool for the interpretation of complex human cancers. , 2008, Journal of proteome research.
[15] R. Reti,et al. Thymosin beta4 is cytoprotective in human gingival fibroblasts. , 2008, European journal of oral sciences.
[16] Sergio E. Baranzini,et al. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets , 2008, Nature.
[17] R. Reynolds,et al. Remyelination can be extensive in multiple sclerosis despite a long disease course , 2007, Neuropathology and applied neurobiology.
[18] T. Montine,et al. Proteomic Identification of Novel Proteins in Cortical Lewy Bodies , 2007, Brain pathology.
[19] R. Caprioli,et al. Identification of proteins directly from tissue: in situ tryptic digestions coupled with imaging mass spectrometry. , 2007, Journal of mass spectrometry : JMS.
[20] Hans Lassmann,et al. Remyelination is extensive in a subset of multiple sclerosis patients. , 2006, Brain : a journal of neurology.
[21] Mahlon D. Johnson,et al. Proteomics in Diagnostic Neuropathology , 2006, Journal of neuropathology and experimental neurology.
[22] H. Lassmann,et al. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis , 2006, Neurological Sciences.
[23] Hans Lassmann,et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.
[24] L. Bö,et al. The Pathology of Multiple Sclerosis Is Location-Dependent: No Significant Complement Activation Is Detected in Purely Cortical Lesions , 2005, Journal of neuropathology and experimental neurology.
[25] F. Holsboer,et al. In-depth analysis of the human CSF proteome using protein prefractionation , 2004, Clinical Proteomics.
[26] Richard M Caprioli,et al. Molecular profiling of experimental Parkinson's disease: direct analysis of peptides and proteins on brain tissue sections by MALDI mass spectrometry. , 2004, Journal of proteome research.
[27] Frederik Barkhof,et al. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. , 2003, Archives of neurology.
[28] A. Otto,et al. beta-Thymosins, small acidic peptides with multiple functions. , 2001, The international journal of biochemistry & cell biology.
[29] R. Wank,et al. Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors. , 1999, Journal of immunology.
[30] Hans Lassmann,et al. Activated Human T Cells, B Cells, and Monocytes Produce Brain-derived Neurotrophic Factor In Vitro and in Inflammatory Brain Lesions: A Neuroprotective Role of Inflammation? , 1999, The Journal of experimental medicine.
[31] W. Brück,et al. Macrophages in multiple sclerosis. , 1996, Immunobiology.
[32] T. Hökfelt,et al. Induction of Thymosin β4 mRNA Following Focal Brain Ischemia , 1996 .
[33] L. Nencioni,et al. Nerve Growth Factor Is an Autocrine Survival Factor for Memory B Lymphocytes , 1996, Cell.
[34] H. Wacker,et al. Detection of a monocyte/macrophage differentiation antigen in routinely processed paraffin-embedded tissues by monoclonal antibody Ki-M1P. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[35] C. Barr,et al. Differential expression of the human thymosin-beta 4 gene in lymphocytes, macrophages, and granulocytes. , 1987, Journal of immunology.